Summary
Tissue engineering might bear promising solutions for overcoming the limitations of biological and mechanical heart valve substitutes. The concept of heart valve tissue engineering bases on decellularized biological matrices, as removal of cellular components might reduce immunological reactions, which are thought to be responsible for accelerated valvular graft deterioration and their subsequent repopulation with autologous cells, which leads to tissue integrity and continuous remodeling. Here, we report a method for efficient removal of cells from ovine heart valve tissue (including cusp, wall, and myocardial cuff) by detergents for the generation of biological valvular scaffolds.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schoen, F. J. and Levy, R. J. (2005) Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann. Thorac. Surg. 79, 1072–1080.
den Hamer, I., Hepkema, B., Prop, J., Elzenga, N., and Ebels, T. (1997) HLA antibodies specific for cryopreserved heart valve “homografts” in children. J. Thorac. Cardiovasc. Surg. 113, 417–419.
Yankah, A. C., Alexi-Meskhishvili, V., Weng, Y., Berger, F., Lange, P., and Hetzer, R. (1995) Performance of aortic and pulmonary homografts in the right ventricular outflow tract in children. J. Heart Valve Dis. 4, 392–395.
Elkins, R. C., Dawson, P. E., Goldstein, S., Walsh, S. P., and Black, K. S. (2001) Decellularized human valve allografts. Ann. Thorac. Surg. 71, S428–S432.
Lichtenberg, A., Tudorache, I., Cebotari, S., Suprunov, M., Tudorache, G., Goerler, H., Park, J.-K., Hilfiker-Kleiner, D., Ringes-Lichtenberg, S., Karck, M., Brandes, G., Hilfiker, A., and Haverich, A. (2006) Preclinical testing of tissue engineered heart valves re-endothelialized under simulated physiological conditions. Circulation. 114, 1559–65.
Cebotari, S., Mertsching, H., Kallenbach, K., Kostin, S., Repin, O., Batrinac, A., Kleczka, C., Ciubotaru, A., and Haverich, A. (2002) Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106, I63–I68.
Lichtenberg, A., Breymann, T., Cebotari, S., and Haverich, A. (2006) Cell seeded tissue engineered cardiac valves based on allograft and xenograft scaffolds. Prog. Pediatr. Cardiol. 21, 211–217.
Lichtenberg, A., Cebotari, S., Tudorache, I., Sturz, G., Winterhalter, W., Hilfiker, A., and Haverich, A. (2006) Flow dependent re-endothelialization of tissue engineered heart valves. J. Heart Valve Dis. 15, 287–294.
Lichtenberg, A., Judorache, I., Cebotari, S., Ringes-Lichtenberg, S., Sturz, G., Hoeffler, K., Hurscheler, C., Brandes, G., Hilfiker, A., Haverich, A. (2006) In vitro re-endothelialization of detergent decellularized heart valves under simulated physiological dynamic conditions. Biomaterials 27(23), 4221–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Lichtenberg, A., Cebotari, S., Tudorache, I., Hilfiker, A., Haverich, A. (2007). Biological Scaffolds for Heart Valve Tissue Engineering. In: Hauser, H., Fussenegger, M. (eds) Tissue Engineering. Methods in Molecular Medicine™, vol 140. Humana Press. https://doi.org/10.1007/978-1-59745-443-8_17
Download citation
DOI: https://doi.org/10.1007/978-1-59745-443-8_17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-756-3
Online ISBN: 978-1-59745-443-8
eBook Packages: Springer Protocols